Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Satellos Bioscience Inc T.MSCL

Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this... see more

TSX:MSCL - Post Discussion

Satellos Bioscience Inc > Satellos' muscle regeneration therapy...
View:
Post by db2067 on Nov 25, 2021 11:43am

Satellos' muscle regeneration therapy...

Check out this paper, exciting work here, this is a much higher level of validation than traditional animal models - things are moving ahead quickly with Satellos' muscle regeneration therapy...

Published NOV 2021
Analysis of human satellite cell dynamics on cultured adult skeletal muscle myofibers Peter Feige1, Eve C. Tsai and Michael A. Rudnicki
https://ruor.uottawa.ca/bitstream/10393/41609/1/13395_2020_Article_256.pdf

Here, we report that by utilizing primary human myofibers, we can model human muscle stem cell dynamics in a chemically, physically, and cellularly relevant context. This method is amendable to model human muscle resident stem cells including satellite cells and in the future feasibly other resident cell types in muscle such as fibroadipogenic precursors, mesenchymal cells, fibroblast, pericyte, endothelial cells, and tenocytes [44, 45]. Myofibers can be prepared within 3 h of surgical excision and can be cultured ex vivo for at least 8 days which reflects satellite cell expansion, differentiation, and de novo human myofiber formation. The ability to directly assay genetic pathways in human satellite cells in a relevant context provides an exciting opportunity for pre-clinical testing and to develop causative relationships in human satellite cell signalling
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities